Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2026-02-25 @ 2:41 AM
Study NCT ID:
NCT04397094
Status:
COMPLETED
Last Update Posted:
2020-07-29
First Post:
2020-05-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Theracal Pulpotomy in Primary Molars
Sponsor:
Ain Shams University
Organization:
Study Overview
Official Title:
Theracal Versus Formocresol Pulpotomy in Primary Molars
Status:
COMPLETED
Status Verified Date:
2020-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Light cured silicate based cement (theracal LC) pulpotomy was compared to formocresol pulpotomy in primary molars.
Detailed Description:
sixty primary molars were either treated with Theracal LC or formocresol pulpotomy. Teeth were followed up clinicaly and radiographically for 12 months.
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: